Micro Cap Growth Fund
Daily price w/o sales charge as of 03/23/2023
$13.43
$0.11
YTD Returns w/o sales charge as of 03/23/2023
2.52%
Overall Morningstar RatingsSmall Growth
as of 02/28/2023
Morningstar rated the Lord Abbett Micro Cap Growth Fund class A share 3, 4 and 5 stars among 574, 528 and 399 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 2/28/2023, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 02/28/2023
- Total Net Assets
- $228.45 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.41%
- Fund Net Expense Ratio
- 1.41%
- Number of Holdings
- 77
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.41%
Net 1.41%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 8.17% | -7.20% | 13.41% | 13.38% | 16.37% | 10.09% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.10% | -9.76% | 8.94% | 7.51% | 10.01% | - |
| Russell Microcap® Growth Index | 7.03% | -12.15% | 4.60% | 2.28% | 7.25% | - |
| w/ sales charge | 1.94% | -12.53% | 11.19% | 12.04% | 15.69% | 9.81% |
Fund Expense Ratio :
Gross 1.41%
Net 1.41%
Fund Expense Ratio :
Gross 1.41%
Net 1.41%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | -29.27% | -29.27% | 9.50% | 12.67% | 16.87% | 9.79% |
| Lipper Category Avg. Small-Cap Growth Funds | -26.66% | -26.66% | 3.55% | 6.14% | 9.96% | - |
| Russell Microcap® Growth Index | -29.76% | -29.76% | -0.24% | 1.00% | 7.22% | - |
| w/ sales charge | -33.33% | -33.33% | 7.36% | 11.34% | 16.18% | 9.50% |
Fund Expense Ratio :
Gross 1.41%
Net 1.41%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 02/28/2023View Portfolio
| Holding | Assets |
|---|---|
| TransMedics Group Inc | 3.3% |
| Impinj Inc | 3.2% |
| Rambus Inc | 3.2% |
| Agilysys Inc | 3.1% |
| Ventyx Biosciences Inc | 3.0% |
| Krystal Biotech Inc | 2.6% |
| NerdWallet Inc | 2.5% |
| Pliant Therapeutics Inc | 2.2% |
| Arcellx Inc | 2.1% |
| elf Beauty Inc | 2.1% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/28/2023View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.41%
Net 1.41%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 8.17% | -7.20% | 13.41% | 13.38% | 16.37% | 10.09% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.10% | -9.76% | 8.94% | 7.51% | 10.01% | - |
| Russell Microcap® Growth Index | 7.03% | -12.15% | 4.60% | 2.28% | 7.25% | - |
| w/ sales charge | 1.94% | -12.53% | 11.19% | 12.04% | 15.69% | 9.81% |
Fund Expense Ratio :
Gross 1.41%
Net 1.41%
Fund Expense Ratio :
Gross 1.41%
Net 1.41%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | -29.27% | -29.27% | 9.50% | 12.67% | 16.87% | 9.79% |
| Lipper Category Avg. Small-Cap Growth Funds | -26.66% | -26.66% | 3.55% | 6.14% | 9.96% | - |
| Russell Microcap® Growth Index | -29.76% | -29.76% | -0.24% | 1.00% | 7.22% | - |
| w/ sales charge | -33.33% | -33.33% | 7.36% | 11.34% | 16.18% | 9.50% |
Fund Expense Ratio :
Gross 1.41%
Net 1.41%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2022 | -29.27% | -29.76% |
| 2021 | 3.46% | 0.88% |
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | -3.85% |
| 2014 | 10.83% | 4.30% |
| 2013 | 78.53% | 52.84% |
| 2012 | 2.35% | - |
| 2011 | -5.87% | - |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| 2005 | 2.55% | - |
| 2004 | 25.89% | - |
| 2003 | 49.34% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2023 | - | - | - | - | 2.52% |
| 2022 | -17.22% | -22.57% | 8.17% | 2.02% | -29.27% |
| 2021 | 12.29% | -0.15% | -9.42% | 1.87% | 3.46% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% | 79.42% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% | 34.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% | 2.74% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% | 38.43% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% | 2.07% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% | -6.38% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% | 10.83% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% | 78.53% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% | 2.35% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% | -5.87% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% | 33.77% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% | 52.61% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% | -46.45% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% | 22.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% | 25.37% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% | 2.55% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% | 25.89% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% | 49.34% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% | -30.97% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% | 16.96% |
| 2000 | - | - | -4.83% | -19.30% | -30.76% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 07/31/2021
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| TransMedics Group Inc | Health Care | 3.3% |
| Impinj Inc | Information Technology | 3.2% |
| Rambus Inc | Information Technology | 3.2% |
| Agilysys Inc | Information Technology | 3.1% |
| Ventyx Biosciences Inc | Health Care | 3.0% |
| Krystal Biotech Inc | Health Care | 2.6% |
| NerdWallet Inc | Financials | 2.5% |
| Pliant Therapeutics Inc | Health Care | 2.2% |
| Arcellx Inc | Health Care | 2.1% |
| elf Beauty Inc | Consumer Staples | 2.1% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Ventyx Biosciences Inc | Health Care | 3.5% |
| Agilysys Inc | Information Technology | 3.3% |
| Impinj Inc | Information Technology | 3.1% |
| Rambus Inc | Information Technology | 2.9% |
| Krystal Biotech Inc | Health Care | 2.6% |
| TransMedics Group Inc | Health Care | 2.6% |
| Arcellx Inc | Health Care | 2.5% |
| Pliant Therapeutics Inc | Health Care | 2.4% |
| Heritage-Crystal Clean Inc | Industrials | 2.1% |
| Calix Inc | Information Technology | 2.1% |
| Chefs' Warehouse Inc/The | Consumer Staples | 2.0% |
| AvidXchange Holdings Inc | Information Technology | 2.0% |
| Xenon Pharmaceuticals Inc | Health Care | 2.0% |
| Pacific Biosciences of California Inc | Health Care | 1.9% |
| Silk Road Medical Inc | Health Care | 1.9% |
| Syndax Pharmaceuticals Inc | Health Care | 1.8% |
| Prometheus Biosciences Inc | Health Care | 1.8% |
| PowerSchool Holdings Inc | Information Technology | 1.8% |
| Napco Security Technologies Inc | Information Technology | 1.8% |
| Gogo Inc | Communication Services | 1.7% |
| elf Beauty Inc | Consumer Staples | 1.6% |
| Rocket Pharmaceuticals Inc | Health Care | 1.6% |
| Xponential Fitness Inc | Consumer Discretionary | 1.5% |
| Remitly Global Inc | Information Technology | 1.5% |
| Flywire Corp | Information Technology | 1.5% |
| Day One Biopharmaceuticals Inc | Health Care | 1.5% |
| NV5 Global Inc | Industrials | 1.5% |
| ICF International Inc | Industrials | 1.5% |
| JFrog Ltd | Information Technology | 1.4% |
| AeroVironment Inc | Industrials | 1.4% |
| Ameresco Inc | Industrials | 1.3% |
| Axonics Inc | Health Care | 1.3% |
| Oxford Industries Inc | Consumer Discretionary | 1.2% |
| Monarch Casino & Resort Inc | Consumer Discretionary | 1.2% |
| C3.ai Inc | Information Technology | 1.2% |
| Aehr Test Systems | Information Technology | 1.2% |
| Warby Parker Inc | Consumer Discretionary | 1.2% |
| Fiverr International Ltd | Industrials | 1.1% |
| Montrose Environmental Group Inc | Industrials | 1.1% |
| indie Semiconductor Inc | Information Technology | 1.1% |
| Karuna Therapeutics Inc | Health Care | 1.1% |
| NerdWallet Inc | Financials | 1.1% |
| Carpenter Technology Corp | Materials | 1.1% |
| Phreesia Inc | Health Care | 1.0% |
| Talos Energy Inc | Energy | 1.0% |
| Titan Machinery Inc | Industrials | 1.0% |
| Ooma Inc | Communication Services | 1.0% |
| BELLUS Health Inc | Health Care | 1.0% |
| Bowlero Corp | Consumer Discretionary | 0.9% |
| Byline Bancorp Inc | Financials | 0.9% |
| Treace Medical Concepts Inc | Health Care | 0.9% |
| uniQure NV | Health Care | 0.9% |
| PROCEPT BioRobotics Corp | Health Care | 0.8% |
| MGP Ingredients Inc | Consumer Staples | 0.8% |
| Olink Holding AB | Health Care | 0.8% |
| Avid Technology Inc | Information Technology | 0.8% |
| Piper Sandler Cos | Financials | 0.8% |
| Kura Sushi USA Inc | Consumer Discretionary | 0.8% |
| AAR Corp | Industrials | 0.8% |
| Cytek Biosciences Inc | Health Care | 0.8% |
| Integral Ad Science Holding Corp | Communication Services | 0.7% |
| Intra-Cellular Therapies Inc | Health Care | 0.7% |
| OSI Systems Inc | Information Technology | 0.7% |
| Sight Sciences Inc | Health Care | 0.7% |
| Esperion Therapeutics Inc | Health Care | 0.7% |
| Vita Coco Co Inc/The | Consumer Staples | 0.7% |
| StoneX Group Inc | Financials | 0.6% |
| Zeta Global Holdings Corp | Information Technology | 0.6% |
| CEVA Inc | Information Technology | 0.6% |
| Yext Inc | Information Technology | 0.5% |
| ZipRecruiter Inc | Communication Services | 0.5% |
| IVERIC bio Inc | Health Care | 0.5% |
| Lantheus Holdings Inc | Health Care | 0.5% |
| Akoya Biosciences Inc | Health Care | 0.4% |
| Arteris Inc | Information Technology | 0.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/28/2023
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.2%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
 0.9%
|
|
| Consumer Staples |
1.2%
|
|
| Energy |
1.0%
|
|
| Financials |
1.5%
|
|
| Health Care |
2.1%
|
|
| Industrials |
3.2%
|
|
| Information Technology |
3.2%
|
|
| Materials |
0.1%
|
Portfolio Details as of 02/28/2023
- Total Net Assets
- $228.45 M
- Number of Holdings
- 77
- Weighted Average Market Cap.
- 2.2 B
- P/B Ratio
- 5.1x
- P/E Ratio
- 15.7x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 03/23/2023
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/20/2023 | 11/21/2023 | 11/21/2023 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 03/23/2023
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $14.25 |
| $50,000 to $99,999 | 4.75% | 4.00% | $14.10 |
| $100,000 to $249,999 | 3.95% | 3.25% | $13.98 |
| $250,000 to $499,999 | 2.75% | 2.25% | $13.81 |
| $500,000 to $999,999 | 1.95% | 1.75% | $13.70 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $13.43 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 02/28/2023
| Fund Gross Expense Ratio | Fund Net Expense Ratio | |
|---|---|---|
| 1.41% | 1.41% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||